Name | N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide |
---|---|
Synonyms |
N-benzoyl-5-methylcytidine
N4-Benzoyl-5-methyl cytidine Cytidine,N-benzoyl-5-methyl |
Description | N4-Benzoyl-5-methylcytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
---|---|
Related Catalog | |
References |
Molecular Formula | C17H19N3O6 |
---|---|
Molecular Weight | 361.35 |
Exact Mass | 361.12700 |
PSA | 137.40000 |
~% 160107-15-3 |
Literature: Alnylam Pharmaceuticals, Inc. Patent: US2006/35254 A1, 2006 ; |
~% 160107-15-3 |
Literature: Wang, Shaohui; Xu, Yanzheng; Kool, Eric T. Bioorganic and Medicinal Chemistry, 1997 , vol. 5, # 6 p. 1043 - 1050 |
~% 160107-15-3 |
Literature: Wang, Shaohui; Xu, Yanzheng; Kool, Eric T. Bioorganic and Medicinal Chemistry, 1997 , vol. 5, # 6 p. 1043 - 1050 |
~% 160107-15-3 |
Literature: Wang, Shaohui; Xu, Yanzheng; Kool, Eric T. Bioorganic and Medicinal Chemistry, 1997 , vol. 5, # 6 p. 1043 - 1050 |
~% 160107-15-3 |
Literature: Wang, Shaohui; Xu, Yanzheng; Kool, Eric T. Bioorganic and Medicinal Chemistry, 1997 , vol. 5, # 6 p. 1043 - 1050 |